⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ILMN

Illumina, Inc.

Healthcare · Diagnostics & Research

205.00USD

-6.0600 (-2.87%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

In $M except per-shareQ2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24
Revenue1,1591,0911,1591,0841,0591,0411,1041,080
Cost of Revenue389370400351364358376335
Gross Profit770721759733695683728745
Operating Income245209201227214164175741
Net Income207134334150235131186705
EPS (Diluted)$1.35$0.87$2.16$0.98$1.49$0.82$1.17$4.42

Source: SEC filings (EDGAR)